CAMBIUM MEDICAL TECHNOLOGIES, LLC

Medtech · Acquired

Standardized platelet lysate eye drops (Elate-Ocular) manufactured from pooled donor platelets for ocular graft-versus-host disease and dry eye treatment

Grants
$149K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Manufacturing pathogen inactivated platelet lysate to treat corneal inflammation$149,265
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1297TSRL, INC.——
1298Activated Research Company, LLC——
1299Fractyl Health—$274M
1300CAMBIUM MEDICAL TECHNOLOGIES, LLC——
1301NAVINETICS NEUROMODULATION, INC.——
1302CENSYN INC——
1303Skelmet, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.